Literature DB >> 8548223

Experience with ileostomy and colostomy in Crohn's disease.

S Post1, C Herfarth, H Schumacher, M Golling, G Schürmann, G Timmermanns.   

Abstract

This study involved 746 patients with Crohn's disease treated surgically within a 13-year interval in whom 227 stomas (159 primary, 68 secondary) were created. The main indication (64 per cent) for primary stoma was severe perianal or genital fistulous disease. Revisional surgery for stomal complications was more common following colostomy than ileostomy (31 versus 5 per cent, P < 0.01). Twenty years after the first symptoms of Crohn's disease the cumulative risks of receiving any stoma or a permanent stoma were 41 and 14 per cent respectively. Four parameters were shown by proportional hazards analysis to be independently associated with the risk for any stoma as well as a permanent one; increased risk coincided with rectal inflammation, perianal fistula or abscess, and absence of small intestinal involvement. In addition, long-standing symptomatic disease before the first surgical intervention reduced the risk of a permanent stoma. The long-term chances of closure following temporary stoma were 75 per cent when used for anastomotic protection or avoidance, 79 per cent after postoperative complications, and 40 per cent for perianal or genital fistulas or for rectal inflammation or stenosis. Rectal disease and perianal fistula were the only independent predictors of a low possibility of stoma closure during follow-up.

Entities:  

Mesh:

Year:  1995        PMID: 8548223     DOI: 10.1002/bjs.1800821213

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  11 in total

1.  Management of nonhealing perineal wounds.

Authors:  Jill C Genua; David A Vivas
Journal:  Clin Colon Rectal Surg       Date:  2007-11

2.  Post-operative recurrence of Crohn's disease after definitive stoma: an underestimated risk.

Authors:  Dine Koriche; Corinne Gower-Rousseau; Charbel Chater; Alain Duhamel; Julia Salleron; Noémie Tavernier; Jean-Frédéric Colombel; Benjamin Pariente; Antoine Cortot; Philippe Zerbib
Journal:  Int J Colorectal Dis       Date:  2016-11-24       Impact factor: 2.571

Review 3.  Role of Fecal Diversion in Complex Crohn's Disease.

Authors:  John P Burke
Journal:  Clin Colon Rectal Surg       Date:  2019-07-02

4.  Risk factors for proctectomy in consecutive Crohn's colitis surgical patients in a reference colorectal centre.

Authors:  Gisele Aaltonen; Monika Carpelan-Holmström; Ilona Keränen; Anna Lepistö
Journal:  Int J Colorectal Dis       Date:  2019-06-28       Impact factor: 2.571

5.  Evidence-based clinical practice guidelines for Crohn's disease, integrated with formal consensus of experts in Japan.

Authors:  Fumiaki Ueno; Toshiyuki Matsui; Takayuki Matsumoto; Katsuyoshi Matsuoka; Mamoru Watanabe; Toshifumi Hibi
Journal:  J Gastroenterol       Date:  2012-10-23       Impact factor: 7.527

6.  The impact of disease pattern, surgical management, and individual surgeons on the risk for relaparotomy for recurrent Crohn's disease.

Authors:  S Post; C Herfarth; E Böhm; G Timmermanns; H Schumacher; G Schürmann; M Golling
Journal:  Ann Surg       Date:  1996-03       Impact factor: 12.969

7.  Risk of fecal diversion in complicated perianal Crohn's disease.

Authors:  M H Mueller; M Geis; J Glatzle; M Kasparek; T Meile; E C Jehle; M E Kreis; T T Zittel
Journal:  J Gastrointest Surg       Date:  2007-04       Impact factor: 3.452

8.  Correlation of the Rutgeerts score and recurrence of Crohn's disease in patients with end ileostomy.

Authors:  Vasutakarn Chongthammakun; Andre Fialho; Andrea Fialho; Rocio Lopez; Bo Shen
Journal:  Gastroenterol Rep (Oxf)       Date:  2016-12-30

9.  No Association between staging operation and the 5-Year Risk of Reoperation in Patients with Crohn's Disease.

Authors:  Jiajie Zhou; Yi Li; Jianfeng Gong; Weiming Zhu
Journal:  Sci Rep       Date:  2019-01-22       Impact factor: 4.379

10.  Restoration of intestinal continuity after stoma formation for Crohn's disease in the era of biological therapy : A retrospective cohort study.

Authors:  Catharina Müller; Michael Bergmann; Anton Stift; Stanislaus Argeny; Doug Speake; Lukas Unger; Stefan Riss
Journal:  Wien Klin Wochenschr       Date:  2020-01-08       Impact factor: 1.704

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.